Göm menyn

Publications for Thomas Schön

Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 101 times*

Journal Articles

Jerker Jonsson, Anna Westman, Judith Bruchfeld, Erik Sturegard, Hans Gaines and Thomas Schön
  A borderline range for Quantiferon Gold In-Tube results
  PLoS ONE, 2017, 12(11), .
   Fulltext  PDF  

Hanna Woksepp, Anna Ryberg, Linda Berglind, Thomas Schön and Jan Söderman
  Epidemiological characterization of a nosocomial outbreak of extended spectrum -lactamase Escherichia coli ST-131 confirms the clinical value of core genome multilocus sequence typing
  Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 2017, 125(12), 1117-1124.

Dumitru Chesov, Nelly Ciobanu, Christoph Lange, Thomas Schön, Jan Heyckendorf and Valeriu Crudu
  Lack of evidence of isoniazid efficacy for the treatment of MDR/XDR-TB in the presence of the katG 315T mutation
  European Respiratory Journal, 2017, 50(4), .

Thomas Schön and Erja Chryssanthou
  Minimum inhibitory concentration distributions for Mycobacterium avium complex-towards evidence-based susceptibility breakpoints
  International Journal of Infectious Diseases, 2017, 55, 122-124.
   Fulltext  PDF  

Thomas Schön, P. Miotto, C. U. Koeser, M. Viveiros, E. Boettger and E. Cambau
  Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives
  Clinical Microbiology and Infection, 2017, 23(3), 154-160.
 Web of Science® Times Cited: 10

Jonna Idh, Blanka Andersson, Maria Lerm, Johanna Raffetseder, Daniel Eklund, Hanna Woksepp, Jim Werngren, Mikael Mansjo, Tommy Sundqvist, Olle Stendahl and Thomas Schön
  Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages
  PLoS ONE, 2017, 12(7), .
   Fulltext  PDF  

Yoshio Nakatani, Helen K. Opel-Reading, Matthias Merker, Diana Machado, Sonke Andres, S. Siva Kumar, Danesh Moradigaravand, Francesc Coll, Joao Perdigao, Isabel Portugal, Thomas Schön, Dina Nair, K. R. Uma Devi, Thomas A. Kohl, Patrick Beckert, Taane G. Clark, Gugu Maphalala, Derrick Khumalo, Roland Diel, Kadri Klaos, Htin Lin Aung, Gregory M. Cook, Julian Parkhill, Sharon J. Peacock, Soumya Swaminathan, Miguel Viveiros, Stefan Niemann, Kurt L. Krause and Claudio U. Koser
  Role of Alanine Racemase Mutations in Mycobacterium tuberculosis D-Cycloserine Resistance
  Antimicrobial Agents and Chemotherapy, 2017, 61(12), .
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Adebisi Ajileye, Nataly Alvarez, Matthias Merker, Timothy M. Walker, Suriya Akter, Kerstin Brown, Danesh Moradigaravand, Thomas Schön, Soenke Andres, Viola Schleusener, Shaheed V. Omar, Francesc Coll, Hairong Huang, Roland Diel, Nazir Ismail, Julian Parkhill, Bouke C. de Jong, Tim E. A. Peto, Derrick W. Crook, Stefan Niemann, Jaime Robledo, E. Grace Smith, Sharon J. Peacock and Claudio U. Koeser
  Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays
  Antimicrobial Agents and Chemotherapy, 2017, 61(4), .
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Meseret Workineh, Biniam Mathewos, Beyene Moges, Adissu Gize, Sisay Getie, Olle Stendahl, Thomas Schön and Ebba Abate
  Vitamin D deficiency among newly diagnosed tuberculosis patients and their household contacts: a comparative cross-sectional study
  Archives of Public Health, 2017, 75, .

Jimmy Fridlund, Hanna Woksepp and Thomas Schön
  A microbiological method for determining serum levels of broad spectrum beta-lactam antibiotics in critically ill patients
  Journal of Microbiological Methods, 2016, 129, 23-27.

Katarina Niward, Kristian Ängeby, Erja Chryssanthou, Jakob Paues, Judith Bruchfeld, Pontus Jureen, Christian G Giske, Gunnar Kahlmeter and Thomas Schön
  Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.
  Journal of Antimicrobial Chemotherapy, 2016, 71(2), 333-338.
 Web of Science® Times Cited: 7

Xia Yu, Guirong Wang, Suting Chen, Guomei Wei, Yuanyuan Shang, Lingling Dong, Thomas Schön, Danesh Moradigaravand, Julian Parkhill, Sharon J. Peacock, Claudio U. Koser and Hairong Huang
  Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin
  Antimicrobial Agents and Chemotherapy, 2016, 60(9), 5232-5237.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Ebba Abate, Meseret Belayneh, Jonna Idh, Ermias Diro, Daniel Elias, Sven Britton, Abraham Aseffa, Olle Stendahl and Thomas Schön
  Asymptomatic Helminth Infection in Active Tuberculosis Is Associated with Increased Regulatory and Th-2 Responses and a Lower Sputum Smear Positivity
  PLoS Neglected Tropical Diseases, 2015, 9(8), .
   Fulltext  PDF  
 Web of Science® Times Cited: 7

E. Abate, D. Elias, A. Getachew, S. Alemu, E. Diro, S. Britton, A. Aseffa, Olle Stendahl and Thomas Schön
  Effects of albendazole on the clinical outcome and immunological responses in helminth co-infected tuberculosis patients: a double blind randomised clinical trial
  International Journal of Parasitology, 2015, 45(2-3), 133-140.
 Web of Science® Times Cited: 10

L. Davies Forsman, C. G. Giske, J. Bruchfeld, Thomas Schön, P. Jureen and K. Angeby
  Meropenem-Clavulanic Acid Has High In Vitro Activity against Multidrug-Resistant Mycobacterium tuberculosis
  Antimicrobial Agents and Chemotherapy, 2015, 59(6), 3630-3632.
   Fulltext  PDF  
 Web of Science® Times Cited: 6

Sten Skogmar, Thomas Schön, Taye Tolera Balcha, Erik Sturegard, Marianne Jansson and Per Bjorkman
  Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count
  PLoS ONE, 2015, 10(12), e0144292.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

W. Wedajo, Thomas Schön, A. Bedru, T. Kiros, E. Hailu, T. Mebrahtu, L. Yamuah, K. Angeby, J. Werngren, P. Onyebujoh, K. Dagne and A. Aseffa
  A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting
  BMC Research Notes, 2014, 7(1), 512.
   Fulltext  PDF  

Marie C Larsson, Maria Lerm, Kristian Ängeby, Michaela Nordvall, Pontus Jureen and Thomas Schön
  A luciferase-based assay for rapid assessment of drug activity against Mycobacterium tuberculosis including monitoring of macrophage viability
  Journal of Microbiological Methods, 2014, 106, 146-150.
 Web of Science® Times Cited: 2

Taye T. Balcha, Niclas Winqvist, Erik Sturegard, Sten Skogmar, Anton Reepalu, Zelalem H. Jemal, Gudeta Tibesso, Thomas Schön and Per Bjorkman
  Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres
  Tropical medicine & international health, 2014, 19(6), 734-742.
 Web of Science® Times Cited: 13

Sten Skogmar, Taye T. Balcha, Zelalem H. Jemal, Jonas Bjork, Wakgari Deressa, Thomas Schön and Per Bjorkman
  Development of a clinical scoring system for assessment of immunosuppression in patients with tuberculosis and HIV infection without access to CD4 cell testing - results from a cross-sectional study in Ethiopia
  Global Health Action, 2014, 7(23105), .
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Hanna Woksepp, Anna Ryberg, Hanna Billstrom, Anita Hällgren, Lennart E Nilsson, Britt-Inger Marklund, Barbro Olsson-Liljequist and Thomas Schön
  Evaluation of High-Resolution Melting Curve Analysis of Ligation-Mediated Real-Time PCR, a Rapid Method for Epidemiological Typing of ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter Species) Pathogens
  Journal of Clinical Microbiology, 2014, 52(12), 4339-4342.
 Web of Science® Times Cited: 5

Taye T. Balcha, Erik Sturegard, Niclas Winqvist, Sten Skogmar, Anton Reepalu, Zelalem Habtamu Jemal, Gudeta Tibesso, Thomas Schön and Per Bjorkman
  Intensified Tuberculosis Case-Finding in HIV-Positive Adults Managed at Ethiopian Health Centers: Diagnostic Yield of Xpert MTB/RIF Compared with Smear Microscopy and Liquid Culture
  PLoS ONE, 2014, 9(1), 85478.
   Fulltext  PDF  
 Web of Science® Times Cited: 33

L. Davies Forsman, Thomas Schön, U. S. H. Simonsson, J. Bruchfeld, Marie C Larsson, P. Jureen, E. Sturegard, C. G. Giske and K. Angeby
  Intra- and Extracellular Activities of Trimethoprim-Sulfamethoxazole against Susceptible and Multidrug-Resistant Mycobacterium tuberculosis
  Antimicrobial Agents and Chemotherapy, 2014, 58(12), 7557-7559.
   Fulltext  PDF  
 Web of Science® Times Cited: 8

Hans Lennart Persson, Daniel Eklund, Amanda Welin, Jakob Paues, Jonna Idh, Sven-Göran Fransson, Olle Stendahl, Maria Lerm and Thomas Schön
  Alveolar macrophages from patients with tuberculosis exhibit reduced capacity of restricting growth of Mycobacterium tuberculosis: a pilot study of vitamin D stimulation in vitro
  HOAJ Biology, 2013, , .
   Fulltext  PDF  

Sten Skogmar, Thomas Schön, Taye Tolera Balcha, Zelalem Habtamu Jemal, Gudeta Tibesso, Jonas Bjork and Per Bjorkman
  CD4 Cell Levels during Treatment for Tuberculosis (TB) in Ethiopian Adults and Clinical Markers Associated with CD4 Lymphocytopenia
  PLoS ONE, 2013, 8(12), 83270.
   Fulltext  PDF  
 Web of Science® Times Cited: 7

Thomas Schon, P Jureen, E Chryssanthou, C G. Giske, G Kahlmeter, S Hoffner and K Angeby
  Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
  Journal of Antimicrobial Chemotherapy, 2013, 68(9), 2074-2077.
 Web of Science® Times Cited: 14

Frauke Rudolf, Grethe Lemvik, Ebba Abate, Jay Verkuilen, Thomas Schön, Victor Francisco Gomes, Jesper Eugen-Olsen, Lars Ostergaard and Christian Wejse
  TBscore II: Refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis
  Scandinavian Journal of Infectious Diseases, 2013, 45(11), 825-836.
 Web of Science® Times Cited: 10

Daniel Eklund, Hans Lennart Persson, Marie C. Larsson, Amanda Welin, Jonna Idh, Jakob Paues, Sven-Göran Fransson, Olle Stendahl, Thomas Schön and Maria Lerm
  Vitamin D enhances IL-1β secretion and restricts growth of Mycobacterium tuberculosis in macrophages from TB patients
  International Journal of Mycobacteriology, 2013, 2(1), 18-25.

Helena Janols, Ebba Abate, Jonna Idh, Meseret Senbeto, Sven Britton, Shitaye Alemu, Abraham Aseffa, Olle Stendahl and Thomas Schön
  Early treatment response evaluated by a clinical scoring system correlates with the prognosis of pulmonary tuberculosis patients in Ethiopia: A prospective follow-up study.
  Scandinavian journal of infectious diseases, 2012, 44(11), 828-834.
 Web of Science® Times Cited: 9

Ebba Abate, Meseret Belayneh, Aschalew Gelaw, Jonna Idh, Assefa Getachew, Shitaye Alemu, Ermias Diro, Nigussu Fikre, Sven Britton, Daniel Elias, Abraham Aseffa, Olle Stendahl and Thomas Schön
  The Impact of Asymptomatic Helminth Co-Infection in Patients with Newly Diagnosed Tuberculosis in North-West Ethiopia
  PLoS ONE, 2012, 7(8), .
   Fulltext  PDF  
 Web of Science® Times Cited: 18

Thomas Schön, Jonna Idh, A Westman, D Elias, E Abate, E Diro, F Moges, A Kassu, B Ayele, Tony Forslund, A Getachew, S Britton, Olle Stendahl and Tommy Sundqvist
  Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis - A randomised trial
  Tuberculosis, 2011, 91(5), 370-377.
 Web of Science® Times Cited: 16

Jonna Idh, Ebba Abate, Anna Westman, Daniel Elias, Helena Janols, Aschalew Gelaw, Assefa Getachew, Shitaye Alemu, Abraham Aseffa, Sven Britton, Olle Stendahl and Thomas Schön
  Kinetics of the QuantiFERON((R))-TB Gold In-Tube test during treatment of patients with sputum smear-positive tuberculosis in relation to initial TST result and severity of disease
  Scandinavian journal of infectious diseases, 2010, 42(9), 650-657.
 Web of Science® Times Cited: 6

Ivar Tjernberg, Thomas Schön, Jan Ernerudh, Annika Carlsson-Wistedt, Pia Forsberg and Ingvar Eliasson
  C6-peptide serology as diagnostic tool in neuroborreliosis
  Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 2008, 116(5), 393-399.
 Web of Science® Times Cited: 11

Hana Abdalla, Tony Forslund, Thomas Schön, Olle Stendahl and Tommy Sundqvist
  Effects of CNI-1493 on human granulocyte functions
  Immunobiology, 2006, 211(3), 191-197.
 Web of Science® Times Cited: 1

Thomas Schön, Dawit Wolday, Daniel Elias, Endalkachew Melese, Feleke Mogens, Tesfaye Tessema, Olle Stendahl, Tommy Sundqvist and Sven Britton
  Kinetics of sedimentation rate, viral load and TNF-α in relation to HIV co-infection in tuberculosis
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 2006, 100(5), 483-488.
 Web of Science® Times Cited: 4

D. Elias, H. Akuffo, A. Pawlowski, M. Haile, Thomas Schön and S. Britton
  Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis
  Vaccine, 2005, 23(11), 1326-1334.
 Web of Science® Times Cited: 104

Thomas Schön, G Elmberger, Y Negesse, R Hernandez Pando, Tommy Sundqvist and S Britton
  Local production of nitric oxide in patients with tuberculosis
  The International Journal of Tuberculosis and Lung Disease, 2004, 8(9), 1134-1137.
 Web of Science® Times Cited: 30

Thomas Schön, R. Hernández-Pando, J. Baquera-Heredia, Y. Negesse, L. E. Becerril-Villanueva, J. C. Leon-Contreras, Tommy Sundqvist and Sven Britton
  Nitrotyrosine localization to dermal nerves in borderline leprosy
  British Journal of Dermatology, 2004, 150(3), 570-574.
 Web of Science® Times Cited: 18

Thomas Schön, D. Elias, F. Moges, E. Melese, T. Tessema, Olle Stendahl, Sven Britton and Tommy Sundqvist
  Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
  European Respiratory Journal, 2003, 21(3), 483-488.
 Web of Science® Times Cited: 38

Thomas Schön, R. H. Pando, Y. Negesse, R. Leekassa, Tommy Sundqvist and Sven Britton
  Expression of inducible nitric oxide synthase and nitrotyrosine in borderline leprosy lesions
  British Journal of Dermatology, 2001, 145(5), 809-815.
 Web of Science® Times Cited: 28

R. Hernández-Pando, Thomas Schön, E. H. Orozco, J. Serafin and I. Estradea-Garcia
  Expression of inducible nitric oxide synthase and nitrotyrosineduring the evolution of experimental pulmonary tuberculosis
  Experimental and Toxicological Pathology, 2001, 53(4), 257-265.
 Web of Science® Times Cited: 46

Thomas Schön, Ruth Leekassa, Negussie Gebre, Tommy Sundqvist, Elisabeth Bizuneh and Sven Britton
  High dose prednisolone treatment of leprosy patients undergoing reactions is associated with a rapid decrease in urinary nitric oxide metabolites and clinical improvement
  Leprosy Review, 2000, 71(3), 355-362.
 Web of Science® Times Cited: 8

Thomas Schön, Negussie Gebre, Tommy Sundqvist, Getachew Anderaye and Sven Britton
  Effects of HIV co-infection and chemotherapy on the urinary levels of nitric oxide metabolites in patients with pulmonary tuberculosis
  Scandinavian Journal of Infectious Diseases, 1999, 31(2), 123-126.

Thomas Schön, Negussie Gebre, Tommy Sundqvist, Haile Selassie H/Mariam, Taye Engeda and Sven Britton
  Increased levels of nitric oxide metabolites in urine from leprosy patients in reversal reaction
  Leprosy Review, 1999, 70(1), 52-55.

Ph.D. Theses

Ebba Abate
  The impact of helminth infection in patients with active tuberculosis

  Fulltext PDF

Karl Granström
  Extended target tracking using PHD filters

  Fulltext PDF

Jonna Idh
  The Role of Nitric Oxide in Host Defence Against Mycobacterium tuberculosis: Clinical and Experimental Studies

  Fulltext PDF

Thomas Schön
  Nitric oxide in tuberculosis and leprosy

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.


Responsible for this page: Peter Berkesand
Last updated: 2017-02-21